Physician

Alberto Esquenazi, MD

According to 2025 Medicare claims, Alberto Esquenazi, MD (NPI: 1801843859) practices physical medicine and rehabilitation in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is EINSTEIN PRACTICE PLAN INC (NPI: 1104882786; TIN: 23-2664784) and primary practice location at 19027-2220. Esquenazi is affiliated with the Einstein Care Partners, LLC (ACO ID: A3671), participating under the MSSP model.

Esquenazi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 65 traditional Medicare patients, billed 187 HCPCS/CPT codes, and received $12,271 in Medicare payments. The top billing code was 64642 (Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity). Part D data shows 13 prescription claims totaling $488 in drug costs. DME data shows 155 claims. Open Payments data shows 30 records totaling $64,197. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $34,856 to $12,271. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $4,430 to $488. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	208	586	$34,856
2016	217	973	$36,097
2017	164	2,457	$40,709
2018	132	762	$23,445
2019	108	742	$15,721
2020	72	155	$8,281
2021	55	114	$8,583
2022	60	114	$8,785
2023	64	132	$10,250
2024	65	187	$12,271

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	29	$4,430
2016	N/R	21	$4,325
2017	N/R	20	$3,715
2018	N/R	26	$4,391
2019	N/R	21	$1,625
2020	N/R	N/R	N/R
2021	N/R	11	$11
2022	N/R	11	$15
2023	N/R	N/R	N/R
2024	N/R	13	$488

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	18	$1,347
2016	55	55	$12,431
2017	24	37	$6,841
2018	25	26	$6,632
2019	17	18	$1,302
2020	N/R	32	$982
2021	N/R	116	$5,839
2022	N/R	155	$7,451
2023	N/R	120	$4,066
2024	N/R	155	$4,525

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64642	Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity	12	24	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	32	45	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	12	15	$53
95873	Electrical stimulation for guidance with injection of chemical for paralysis of nerve muscle	11	18	$15
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	24	27	$14

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	37	$2,398
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	39	$815
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	43	$672
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	36	$640

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$39,888	Ipsen Innovation
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$24,309	Ipsen Pharma SAS
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alberto Esquenazi, MD?

Tedicare shows public-source Medicare data for Alberto Esquenazi, MD (NPI 1801843859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto Esquenazi, MD have ACO affiliation data?

Alberto Esquenazi, MD is shown with ACO affiliation data for Einstein Care Partners, LLC (MSSP, ACO ID A3671).

What billing organization is linked to Alberto Esquenazi, MD?

Alberto Esquenazi, MD is linked to EINSTEIN PRACTICE PLAN INC (billing NPI 1104882786) in the available physician profile data.

Does Alberto Esquenazi, MD have Open Payments data?

Alberto Esquenazi, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.